Abstract:Objective. The aims of this study were to investigate the impact of TAK-242 on the Toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear transcription factor-κB (NF-κB) signal transduction pathway in rats with hepatic fibrosis (HF) using the liver gut axis and to investigate the molecular mechanism of its intervention on HF. Methods. SPF grade SD male rats were randomly allocated to the control, model, and TAK-242 groups. For 8 weeks, the model and TAK-242 groups received 3 mL·kg-1 (the initial dose 5 mL·kg-1) intraperitoneal injections of 40% CCL4 olive oil solution. TAK-242 (5 mg·kg-1) was administered once a day for 5 days after modeling. The pathological alterations of liver and small intestine tissues in each group were observed using H&E and Masson staining. ELISA was used to measure serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), direct bilirubin (DBIL), total bilirubin (TBIL), interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α). RT-qPCR was utilized to identify the mRNA expression level of IL-1β, IL-6, TNF-α, TLR4, MyD88, and NF-κB in rat liver and small intestine tissues. The protein level of IL-1β, IL-6, TNF-α, TLR4, MyD88, and NF-κB protein in rat liver and small intestine tissues was determined utilizing Western blot and IHC. Results. TAK-242 significantly reduced AST, ALT, TBIL, and DBIL expression in HF rats' serum ( P < 0.01 ) and alleviated liver tissue injury. Hematoxylin-eosin (H&E) and Masson staining revealed inflammatory cell infiltration and fibrous proliferation in the liver and small intestine tissue in the model group and partial cell swelling in the TAK-242 group, which indicated a considerable improvement compared to the model group. RT-qPCR, Western blot, and IHC data indicated that TAK-242 reduced the IL-1β, IL-6, TNF-α, TLR4, MyD88, and NF-κB expression in the liver and small intestine tissues of HF rats. Conclusion. TAK-242 might downregulate the TLR4/MyD88/NF-κB signal pathway through the liver-gut axis, suppress the inflammatory response, and eventually alleviate HF in rats.

Leflunomide attenuates hepatocyte injury by inhibiting Kupffer cells.

A 771726, the Active Metabolite of Leflunomide, Inhibits TNF-α and IL-1 from Kupffer Cells

TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis

Inhibitory Effect Of Leflunomide On Hepatic Fibrosis Induced By Ccl4 In Rats

Effect of Leflunomide on Immunological Liver Injury in Mice

Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells.

Inhibition of Hepatic Cytochrome P450 Enzymes and Sodium/bile Acid Cotransporter Exacerbates Leflunomide-Induced Hepatotoxicity.

[Effects of Leflunomide and Its Active Metabolite on the Production and Mrna Expression of TNF-alpha in Peritoneal Macrophages and Synovial Cells with Adjuvant Arthritis in Rats].

Mitochondrial Dysfunction Induced by Leflunomide and Its Active Metabolite.

SINGLE NUCLEOTIDE POLYMORPHISM IN IFN WAS ASSOCIATED WITH ACUTE REJECTION AFTER LIVER TRANSPLANTATION

Leflunomide inhibits inflammation and apoptosis of H9c2 cells induced by hydrogen peroxide

Leflunomide Induces Immunosuppression in Collagen-Induced Arthritis Rats by Upregulating CD4+CD25+ Regulatory T Cells.

[The active metabolite of leflunomide A771726 inhibits proliferation and collagen synthesis of hepatic stellate cell].

Endoplasmic Reticulum Stress and MAPK Signaling Pathway Activation Underlie Leflunomide-Induced Toxicity in HepG2 Cells.

Leflunomide Active Metabolite Inhibites the Expression of Phorbol-12-myristate-13-acetate-induced CD147,matrix Metallo-Proteinase-2 and Matrix Metallo-Proteinase-9 on THP-1 Cells

Effect of active leflunomide metabolite on NF-κB activity and TNF-α mRNA expression in overload albumin stimulating proximal tubular cells

Osteoclast Differentiation Inhibited by Active Metabolite of Leflunomide through Regulating NFATc1 Expression

The Potential Role of Leflunomide in Inhibiting Vascular Fibrosis by Down-Regulating Type-Ii Macrophages in Takayasu's Arteritis.

Inhibiting Effects of Leflunomide Metabolite on Overexpression of CD147, MMP-2 and MMP-9 in PMA Differentiated THP-1 Cells.

Dynamic Effects of Leflunomide on IL-1, IL-6, and TNF-alpha Activity Produced from Peritoneal Macrophages in Adjuvant Arthritis Rats.

Leflunomide Induces Pulmonary and Hepatic CYP1A Enzymes Via Aryl Hydrocarbon Receptor